Body surfaces are colonized by resident microbes that are remarkably resilient to recurrent immune responses. In the latest issue of Science, Cullen et al. (2015) report that, contrary to prevailing assumptions, bacteria of the colonizing microbiota are resistant to antimicrobial peptides, and identify a common mechanism of resistance.
Metazoans have coevolved with resident microbes at body surfaces exposed to the environment. These microbes, referred to as the colonizing microbiota, influence physiology and in many cases can benefit the host. While environmental factors influence the composition of the microbiota, many studies have shown that host factors also shape the makeup of these microbial ecosystems. One host factor that influences the colonizing microbiota is a collection of surfaceexpressed antimicrobial peptides (AMPs) (Bevins and Salzman, 2011) . These AMPs are key contributors to innate immune host protection from virulent pathogens, where their production and/ or release onto the body surface are typically on-demand regulated processes. Investigations of virulence mechanisms of several bacterial pathogens have identified specific mechanisms leading to AMP resistance. A broadly held assumption holds that the resident microbiota, in contrast to pathogens, are likely sensitive to the antimicrobial activity of AMPs, since AMP resistance is identified as an indispensable virulence trait for some bacterial pathogens. The latter concept was first introduced by work on Salmonella enterica, an intracellular pathogen that requires inducible AMP resistance mechanisms for survival within macrophages (Fields et al., 1989) . A newly published study by Cullen et al. (2015) turns previous assumptions upside down by showing that a dominant group of commensal bacteria of the mammalian intestinal tract is resistant to membranetargeting AMPs and that this resistance enables these bacteria to maintain colonization during inflammation.
Depending on the particular body site, the abundance and composition of the microbiota varies greatly. Compared to most sites, the intestinal tract of humans, and many other mammals, harbors the greatest abundance of bacteria and other microbes. Bacteroidetes and Firmicutes are by far the most dominant bacterial phyla, but at the genus and species levels, diversity is tremendous, with estimates of hundreds to thousands of species-level bacteria inhabiting the gut. A key beneficial function of this intestinal microbiota is to salvage calories and nutrients from otherwise indigestible components in the diet. This abundant and very complex microbial community exists as an open ecosystem that can be influenced by not only diet, but also other environmental factors. The community structure is typically resilient, and the composition remains surprisingly stable in the longer term, despite often dramatic transient shifts in composition that occur in response to the host inflammatory responses that can accompany, for example, mucosal invasion by pathogens. A prominent facet of the host innate immune response to such pathogens is the elaboration of AMPs into the intestinal lumen. In S. enterica, the polymyxin resistance (Pmr)A/PmrB regulatory system controls expression of AMP resistance genes, which are involved in adding ethanolamine or 4-amino-4deoxy-L-arabinose moieties to phosphate groups in the lipid A moiety of lipopolysaccharide (LPS) or the LPS core region (Gunn, 2008) . These phosphate modifications decrease negative charge on the bacterial surface, impairing activity of cationic AMPs (Figure 1 ). Inactivation of pmrA/pmrB attenuates S. enterica virulence when mice are infected orally, but not when the intestinal lumen is circumvented by a peritoneal route of infection (Gunn et al., 2000) . These data suggest that AMP resistance is required by enteric pathogens to survive in the intestine. Cullen et al. (2015) determined the sensitivity of a collection of common intestinal commensal Firmicutes and Bacteroidetes, including Bacteroides thetaiotaomicron, to several AMPs, including human a-defensin 5 (HD5), cathelicidins (of mouse and human origin), and polymyxin B (PMB), a readily available, cationic, membrane-active AMP of bacterial origin that is often used as a surrogate for host cationic AMPs. The findings were remarkable. As compared to the sensitivity of E. coli and three Gram-negative Proteobacteria enteropathogens, the commensal bacteria were generally between 4-fold (versus HD5) and 1,000fold (versus PMB) more resistant to the bactericidal activity of AMPs, a trait not assumed to be common within gut-associated microbial communities.
In order to determine the mechanism of this resistance, Cullen et al. (2015) screened transposon mutant libraries of five commensal bacteria to identify genes necessary for fitness in the presence of PMB. A single gene responsible for resistance (BT1854/LpxF) was identified and functionally confirmed by targeted deletion and complementation experiments. This gene encodes a phosphatase that was shown responsible for cationic AMP resistance by removing a phosphate from lipid A, which in turn decreases the negative surface charge on bacteria and impedes AMP binding and subsequent membrane disruption (Figure 1 ). In vivo competition experiments in gnotobiotic mice showed that whereas lpxF-deleted strains competed favorably with wildtype and complemented strains of B. thetaiotaomicron under noninflammatory conditions, the deficient strain was rapidly outcompeted when the intestinal tract was inflamed by a bacterial pathogen (Citrobacter rodentium) or by chemical provocation (DSS). The requirement for an intact lpxF gene for B. thetaiotaomicron colonization and resilience following inflammation was further demonstrated in the presence of gut microbiota of increased complexity, including gnotobiotic mice harboring a collection of 14 bacterial species and in specific-pathogen-free Rag À/À mice. Complementation experiments in vitro showed similar competitive differences between lpxF competent and incompetent strains when mixtures of B. thetaiotaomicron were exposed to AMPs.
The broader relevance of this resistance mechanism was evident when the genomes of 50+ human-associated Bacteroidetes all revealed the presence of lpxF orthologs, and seven of seven lipid A structures from a sampling of these bacteria showed hypophosphorylation. Furthermore, over 700 cultured specieslevel phylotypes obtained directly from 12 individuals (representing approximately 95% of the donors' original uncultured microbiota at the class and order level) showed AMP resistance in vitro, especially notable for isolated Actinobacteria, Firmicutes, and Bacteroidetes.
As wide reaching as the findings may be, no one would expect that a single mechanism would fully explain the dy-namics of the interactions between resident bacteria and host AMPs. Although targeted membrane disruption is common to many AMPs and is most often the mode of antimicrobial action associated with these peptides, some defensins and other AMPs function via membraneindependent mechanisms (Hale and Hancock, 2007) . For example, Lu and colleagues (Wei et al., 2009) reported that while the D-and L-enantiomers of human neutrophil a-defensin 1 (HNP1) and HD5 were equally bactericidal against Gramnegative bacteria, the D-enantiomers were significantly less active than their native L-forms in the killing of Gram-positive bacteria. Recognizing that chiralityindependent activity characterizes membrane-disruptive mechanisms, further studies by Lu and colleagues (de Leeuw et al., 2010) sought alternative bacterial targets. They determined that HNP1 interacts functionally with lipid II, an essential precursor of cell wall synthesis in Grampositive bacteria. Their findings point to inhibition of peptidoglycan biosynthesis through binding of lipid II as a key mechanism for killing of Gram-positive bacteria by some defensins. Similarly, the abundant human enteric antimicrobial polypeptide Reg3a has a nuanced mechanism of action against Gram-positive bacteria. For this C-type lectin, initial attraction to the bacterial surface is mediated by binding peptidoglycan carbohydrate, which is then followed by assembly of a membrane attack complex to form a hexameric membrane-permeabilizing bactericidal pore (Mukherjee et al., 2014) . Other prominent AMPs of the intestinal tract, such as group 2 secretory phospholipase A2 and lysozyme, utilize enzymatic activity to mount bactericidal activity (Bevins and Salzman, 2011) . The pioneering study by Cullen et al. (2015) should prompt future investigation on possible resistance mechanisms of commensal microbiota to these abundant AMPs with alternative modes of antimicrobial activity.
Given that resident microbes have coevolved with host-derived AMPs in the intestinal tract, it probably should have been less of a surprise that commensal microbiota are relatively resistant to AMPs, despite over two decades of inaccurate assumptions. Based on elegant studies of host-microbe interactions on the surface of the invertebrate Hydra, and citing compelling evidence that components of innate immunity, including AMPs, play a vital role in establishing host-specific microbiota at colonized body surfaces, Bosch (2013) proposed a provocative hypothesis that challenges After trafficking to the surface, Lipid A of Gram-negative bacteria can undergo derivitization or (as newly described) removal of phosphate groups to render bacteria resistant to AMPs by decreasing negative charge of the outer membrane.
Cell Host & Microbe
Previews the prevailing view that immune systems have evolved exclusively to control invading pathogens. Instead, Bosch suggests that immune systems evolved because of the need to control the resident beneficial microbes. The new insights obtained by Cullen et al. (2015) are aligned with such a notion, but with a twist, in that relative AMP resistance appears to be a phenotype selected by host immune factors. The new work should now provide a more accurate view of the intricacies of host-microbe interactions and inspire new hypotheses on critical host-microbe interplay at mucosal surfaces.
Both environmental factors and host genetics shape the composition of gut microbiota in mammals, but what matters more is insufficiently understood. In this issue of Cell Host & Microbe, Carmody et al. (2015) show that diet can overrule genotype-related differences in gut microbiota composition in different mouse populations.
The gut microbiome is considered an important determinant of human health, and therefore identifying the mechanisms by which communities are assembled and structured is of significant interest. When considering a human population as a whole, the gut microbiota constitutes a metacommunity dominated by around 70 bacterial species (Schloissnig et al., 2013) . Within individuals, species and strains are for the most part stably maintained over years, but community membership and relative abundance of members differs markedly among individuals (referred to as b-diversity). What causes this substantial degree of inter-individual variation remains a key question in the field. In a paper published this issue of Cell Host & Microbe, a research team led by Peter Turnbaugh investigated whether host genotype or diet are the dominant drivers of gut microbiota struc-ture (Carmody et al., 2015) . Host genotype has a measurable impact on gut microbiota composition in both mice (Benson et al., 2010) and humans (Goodrich et al., 2014) , but does not explain most inter-individual variation as monozygotic twins, although slightly more similar than dizygotic twins, still exhibit a substantial degree of individuality (Goodrich et al., 2014) .
To determine what matters more, host genotype or diet, Turnbaugh's team fed two distinct diets, a low-fat, high-plant polysaccharide diet; LFPP, and a highfat, high-sugar diet; HFHS, to five inbred mouse strains (129S1/SvImJ, A/J, C57BL/6J, NOD/LtJ, and NZO/HlLtJ), mice deficient for genes with an established role in shaping the gut microbiota (MyD88À/À, NOD2À/À, ob/ob, and Rag1À/À), and a population of outbred mice (the Diversity Outbred population).
In all cases, the HFHS diet led to reproducible shifts in the fecal microbiota, causing the bacterial communities to cluster primarily by diet. Sub-clustering by genotype was observed for both the inbred and knockout mouse lines, confirming the importance of host genes in shaping the microbiome (Benson et al., 2010; Goodrich et al., 2014) . However, the genetic influence was clearly secondary to that of diet.
The research team then shifted its focus to the temporal dynamics of diet-induced microbiome shifts and the consequence of repeated dietary disturbances on community composition, using the outbred mice. These experiments revealed some intriguing insight into the specifics of diet-induced perturbations. Shifts in response to the HFHS diet occurred fast, with altered communities reaching a new steady state within 3 days in mice
